We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

249 hedge funds and large institutions have $3.58B invested in Abiomed Inc in 2015 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 104 increasing their positions, 75 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 75

21% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 33

2% more funds holding

Funds holding: 243249 (+6)

8% more call options, than puts

Call options by funds: $8.21M | Put options by funds: $7.62M

3% less capital invested

Capital invested by funds: $3.68B → $3.58B (-$94.3M)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
249
Holders Change
+6
Holders Change %
+2.47%
% of All Funds
6.53%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
40
Increased
104
Reduced
75
Closed
33
Calls
$8.21M
Puts
$7.62M
Net Calls
+$593K
Net Calls Change
-$7.27M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$511M -$934K -11,000 -0.2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$276M -$25.3M -298,309 -9%
PAI
3
Palo Alto Investors
California
$261M +$5.3M +62,500 +2%
BFA
4
BlackRock Fund Advisors
California
$237M +$11.3M +133,319 +5%
EWM
5
Essex Woodlands Management
Texas
$194M
JSP
6
Jackson Square Partners
California
$165M +$13.8M +162,571 +10%
Macquarie Group
7
Macquarie Group
Australia
$111M +$10.8M +127,037 +12%
BIT
8
BlackRock Institutional Trust
California
$87.6M +$1.45M +17,136 +2%
State Street
9
State Street
Massachusetts
$76M +$1.11M +13,131 +2%
William Blair Investment Management
10
William Blair Investment Management
Illinois
$73.1M +$12.8M +151,090 +23%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$66.5M +$923K +10,879 +1%
ORI
12
Oak Ridge Investments
Illinois
$65.1M +$10.4M +122,568 +20%
EAM
13
Eagle Asset Management
Florida
$58.6M +$55.1M +648,785 New
NCGI
14
Next Century Growth Investors
Minnesota
$54.9M +$1.69M +19,885 +3%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$51.4M +$11.5M +135,179 +31%
Northern Trust
16
Northern Trust
Illinois
$46.7M +$1.12M +13,187 +3%
Norges Bank
17
Norges Bank
Norway
$46.4M -$6.56M -77,291 -13%
Lord, Abbett & Co
18
Lord, Abbett & Co
New Jersey
$38.3M -$22.3M -262,893 -38%
VOYA Investment Management
19
VOYA Investment Management
Georgia
$36.2M +$5.09M +60,035 +18%
SI
20
Scout Investments
Missouri
$26.3M +$9.3M +109,577 +60%
GIM
21
Granahan Investment Management
Massachusetts
$26.1M +$18M +211,675 +274%
Baillie Gifford & Co
22
Baillie Gifford & Co
United Kingdom
$25.9M +$24.4M +287,412 New
CCM
23
Cupps Capital Management
Illinois
$25.1M -$6.05M -71,315 -20%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$25M +$1.48M +17,402 +7%
Goldman Sachs
25
Goldman Sachs
New York
$25M +$5.73M +67,497 +32%

ABMD Hedge Fund Activity: Q4 2015 in Review

249 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2015, worth a combined $3.58B — down 2.6% from $3.68B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new ABMD positions and 33 closed out — a net gain of 7 holders — while 104 added to existing stakes and 75 trimmed.

The largest buyer was Eagle Asset Management, opening a new position worth an estimated $55.1M. The largest seller was 1832 Asset Management, exiting entirely with an estimated $104M sold.

  • 249 institutional investors held Abiomed Inc (ABMD) as of Q4 2015, up from 243 in Q3 2015.
  • Funds reported $3.58B of Abiomed Inc stock for Q4 2015, down 2.6% quarter-over-quarter.
  • 40 funds opened new Abiomed Inc positions in Q4 2015 and 33 closed out, a net change of +7 holders.
  • The largest Abiomed Inc buyer in Q4 2015 was Eagle Asset Management, an estimated $55.1M added.
  • The largest Abiomed Inc seller in Q4 2015 was 1832 Asset Management, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2015.